Age-appropriate use of human papillomavirus vaccines in the U.S.
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 114 (2) , 365-369
- https://doi.org/10.1016/j.ygyno.2009.04.035
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian womenBritish Journal of Cancer, 2009
- Health and Economic Implications of HPV Vaccination in the United StatesNew England Journal of Medicine, 2008
- Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and VaccinationThe Journal of Infectious Diseases, 2008
- Is viral status needed before vaccination?Vaccine, 2008
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 VaccinationJNCI Journal of the National Cancer Institute, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsPublished by Elsevier ,2007
- A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial LesionThe Journal of Infectious Diseases, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003